化疗中转移性瘤中药物耐药性的发展:一种进化视角
Federica Padovano1, Chiara Villa2
1Sorbonne Université, CNRS, Université de Paris, Laboratoire Jacques-Louis Lions UMR 7598, 4 place Jussieu, 75005 Paris, France.
这项研究模拟了化疗期间转移性瘤的演变,揭示了耐药性和细胞迁移如何影响治疗. 研究结果表明,化疗可能会增强转移,并降低二次瘤中药物的有效性.
科学领域:
- 数学瘤学数学瘤学
- 计算生物学 计算生物学
- 药理动力学和药理动力学
背景情况:
- 转移性瘤在癌症治疗中存在复杂的挑战.
- 化疗疗效率可能受到药物耐药性和瘤异质性的限制.
- 了解瘤进化,药物输送和转移之间的相互作用至关重要.
研究的目的:
- 开发和分析化学治疗下转移性瘤动态的数学模型.
- 研究细胞迁移,瘤生理学和药物剂量对治疗结果的影响.
- 探索化学抵抗的发展和化疗在初级和转移性部位的有效性.
主要方法:
- 用非局部局部微分方程用于表型结构细胞群的结合数学模型.
- 与基于生理学的药物动力学模型进行集成,以实现现实的药物管理.
- 长期的非对称分析,全球灵敏度分析和数值模拟.
主要成果:
- 该模型解释了从原发性瘤到转移的细胞迁移如何影响治疗.
- 研究结果表明,化疗可能会促进转移性传播.
- 与原发性瘤相比,转移可能对化疗剂的敏感性降低.
结论:
- 数学建模提供了关于化疗下转移性癌症进化动态的见解.
- 化疗方案需要考虑细胞迁移和初级和转移部位之间的药物反应差异.
- 这项研究为癌症治疗中观察到的临床现象提供了潜在的机制性解释.
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
10:24Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
相关概念视频
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Treatment Resistant Cancers
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Treatment Resistent Cancers
